AI assistant
Sending…
IO Biotech, Inc. — Director's Dealing 2023
Jan 13, 2023
34883_dirs_2023-01-13_0dc85661-77cd-4e8b-8102-3beb861ffecf.zip
Director's Dealing
Open in viewerOpens in your device viewer
SEC Form 3 — Initial Statement of Beneficial Ownership
Issuer: IO Biotech, Inc. (IOBT)
CIK: 0001865494
Period of Report: 2023-01-03
Reporting Person: Smith Devin Whittemore (General Counsel)
More from IO Biotech, Inc.
Board/Management Information
2026
Mar 31
Delisting Announcement
2026
Feb 13
Major Shareholding Notification
2026
Feb 13
Major Shareholding Notification
2026
Feb 6
Regulatory Filings
2026
Jan 30
Major Shareholding Notification
2026
Jan 23
Regulatory Filings
2026
Jan 21
Delisting Announcement
2025
Dec 19
Board/Management Information
2025
Nov 21
Investor Presentation
2025
Nov 18